By Reuters
Share this articleComments
(Reuters) - Healthcare conglomerate Johnson & Johnson <JNJ.N> has lost its motion to reverse a verdict that awarded $4.7 billion (3.71 billion pounds) to women who blamed ovarian cancer on asbestos in the company's Baby Powder and other talc products, a Missouri court ruled on Wednesday.
Shares of the company reversed course to slip 0.6 percent to $129.38 in afternoon trading.
(Reporting by Manas Mishra in Bengaluru)
Share this articleComments